These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16465870)

  • 1. [Antibodies--the "magic bullets"?].
    Zündorf I
    Pharm Unserer Zeit; 2006; 35(1):84-5. PubMed ID: 16465870
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic antibodies: magic bullets hit the target.
    Gura T
    Nature; 2002 Jun; 417(6889):584-6. PubMed ID: 12050630
    [No Abstract]   [Full Text] [Related]  

  • 3. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
    Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Magic Bullets" at the center stage of immune therapy: a special issue on therapeutic antibodies.
    An Z
    Protein Cell; 2018 Jan; 9(1):1-2. PubMed ID: 29139027
    [No Abstract]   [Full Text] [Related]  

  • 5. Building better magic bullets--improving unconjugated monoclonal antibody therapy for cancer.
    Weiner LM
    Nat Rev Cancer; 2007 Sep; 7(9):701-6. PubMed ID: 17721434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in monoclonal antibody-based immunotherapy for cancer treatment].
    Guo Y
    Sheng Wu Gong Cheng Xue Bao; 2015 Jun; 31(6):857-70. PubMed ID: 26672362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized antibodies as potential drugs for therapeutic use.
    Merluzzi S; Figini M; Colombatti A; Canevari S; Pucillo C
    Adv Clin Path; 2000 Apr; 4(2):77-85. PubMed ID: 11080787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies as magic bullets.
    Brodsky FM
    Pharm Res; 1988 Jan; 5(1):1-9. PubMed ID: 3072552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magic bullets fly again.
    Ezzell C
    Sci Am; 2001 Oct; 285(4):34-41. PubMed ID: 11570040
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody engineering: facing new challenges in cancer therapy.
    Sanz L; Cuesta AM; Compte M; Alvarez-Vallina L
    Acta Pharmacol Sin; 2005 Jun; 26(6):641-8. PubMed ID: 15916728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status and prospects of antibody engineering for therapeutic use: focus on glycoengineering technology.
    Niwa R; Satoh M
    J Pharm Sci; 2015 Mar; 104(3):930-41. PubMed ID: 25583555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From magic bullets to real drugs--immunotherapy available on the pharmacy's shelves].
    Veromaa T
    Duodecim; 2003; 119(8):793-800. PubMed ID: 12806743
    [No Abstract]   [Full Text] [Related]  

  • 13. Magic bullets at last! Finally--approval of a monoclonal antibody for the treatment of cancer!!!
    Dillman RO
    Cancer Biother Radiopharm; 1997 Aug; 12(4):223-5. PubMed ID: 10851468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibodies against cancer].
    Barriuso Feijóo J; Sundlov A; González Barón M
    Rev Clin Esp; 2004 Dec; 204(12):649-54. PubMed ID: 15710074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of genetically engineered monoclonal antibodies for cancer immunotherapy.
    Reisfeld RA
    Pigment Cell Res; 1992; Suppl 2():109-12. PubMed ID: 1409412
    [No Abstract]   [Full Text] [Related]  

  • 16. Whither magic bullets and guided missiles: monoclonal antibodies 20 years later.
    Dillman RO
    Cancer Biother; 1995; 10(3):177-80. PubMed ID: 8547956
    [No Abstract]   [Full Text] [Related]  

  • 17. "Magic bullets:" from muskets to smart bombs!!!
    Khaw BA; Strauss HW; Narula J
    J Nucl Med; 1993 Dec; 34(12):2264-8. PubMed ID: 8254421
    [No Abstract]   [Full Text] [Related]  

  • 18. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From "magic bullets" to specific cancer immunotherapy.
    Riether C; Schürch C; Ochsenbein AF
    Swiss Med Wkly; 2013; 143():w13734. PubMed ID: 23348718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.